Proassurance Corp

Proassurance Corp (PRA) Stock Analysis

$25.000

0.000 (0.00%)At close

Loading chart…
High
25.010
Open
25.000
VWAP
25.00
Vol
3.38M
Mkt Cap
Low
24.990
Amount
84.55M
EV/EBITDA, TTM
21.55

ProAssurance Corporation is a holding company for property and casualty insurance companies. The Company operates through three segments, which include Specialty Property and Casualty, Workers Compensation Insurance and Segregated Portfolio Cell Reinsurance. Its Specialty Property and Casualty segment focuses on medical professional liability insurance and medical technology liability insurance. Its Workers Compensation Insurance segment offers workers compensation products in 19 core states in the East, South and Midwest regions of the continental United States. Its Segregated Portfolio Cell Reinsurance segment focuses on Segregated portfolio cell (SPCs) at Inova Re and Eastern Re, its Cayman Islands SPC operations. The Company’s insurance subsidiaries provide medical professional liability insurance, liability insurance for medical technology and life sciences risks and workers compensation insurance.

AI analysis of Proassurance Corp (PRA)

hold

Proassurance Corp (PRA) does not present a strong buy opportunity at this time for a beginner investor with a long-term strategy. The technical indicators are neutral to slightly bullish, but there are no significant positive catalysts, trading signals, or financial data available to justify an immediate investment. The options data suggests a mixed sentiment, and the lack of recent news or analyst updates further limits the case for a buy decision.

Analyst Ratings (8)

Hold
2 Buy
6 Hold
0 Sell
Current: 25.00
Low
Average
High

Piper Sandler

2025-05-08

Price Target

$25

Neutral

Citizens Capital Markets

2025-04-03

Price Target

Hold

Truist Securities

2024-11-12

Price Target

$18

Hold

Truist Securities

2024-08-12

Price Target

$14

Hold

JMP Securities

2024-07-17

Price Target

$20

Buy

Valuation Metrics

The current forward P/E ratio for Proassurance Corp (PRA) is 16.86, compared to its 5-year average forward P/E of 216.65.

Forward P/E

Fair
5Y Average P/E
216.65
Current P/E
16.86
Overvalued
1036.08
Undervalued
-602.77

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
1.62
Current EV/EBITDA
21.55
Overvalued
6.69
Undervalued
-3.45

Forward P/S

Overvalued
5Y Average P/S
0.94
Current P/S
1.27
Overvalued
1.17
Undervalued
0.71

Alphio AI Price Scenarios for PRA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PRA

$24.84

Scenario price

B

Base

Base · 50%PRA

$22.83

Scenario price

B

Bear

Bear · 25%PRA

$22.39

Scenario price

Whales holding PRA

W

Westchester Capital Management, LLC

+ HoldingPRA

+2.08%

3M Return

M

Magnetar Capital Partners, LP

+ HoldingPRA

-3.29%

3M Return

Events Timeline

2026-06-26 (ET)

09:30:00

The Doctors Company Acquires ProAssurance for $1.3 Billion

2026-06-03 (ET)

11:30:00

ProAssurance Enters Merger Agreement with The Doctors Company

2026-05-05 (ET)

17:00:00

ProAssurance Reports Q1 Revenue of $262.63M

2026-02-23 (ET)

16:30:00

ProAssurance Q4 Revenue $201.52M, Below Consensus

2025-11-04 (ET)

16:21:40

ProAssurance announces Q3 adjusted earnings per share of 15 cents, falling short of the 26-cent consensus.

News

PRA FAQ — answered by Alphio AI

ProAssurance Corporation is a holding company for property and casualty insurance companies. The Company operates through three segments, which include Specialty Property and Casualty, Workers Compensation Insurance and Segregated Portfolio Cell Reinsurance. Its Specialty Property and Casualty segment focuses on medical professional liability insurance and medical technology liability insurance. Its Workers Compensation Insurance segment offers workers compensation products in 19 core states in the East, South and Midwest regions of the continental United States. Its Segregated Portfolio Cell Reinsurance segment focuses on Segregated portfolio cell (SPCs) at Inova Re and Eastern Re, its Cayman Islands SPC operations. The Company’s insurance subsidiaries provide medical professional liability insurance, liability insurance for medical technology and life sciences risks and workers compensation insurance. It operates in the Financials sector (FIRE, MARINE & CASUALTY INSURANCE industry).

Proassurance Corp (PRA) does not present a strong buy opportunity at this time for a beginner investor with a long-term strategy. The technical indicators are neutral to slightly bullish, but there are no significant positive catalysts, trading signals, or financial data available to justify an immediate investment. The options data suggests a mixed sentiment, and the lack of recent news or analyst updates further limits the case for a buy decision.

8 analysts cover PRA: 2 rate it Buy, 6 Hold and 0 Sell.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started